Healthcare Hires of Note

Check out executive hires from SnapNurse, Almaden Genomics, Dr. Evidence,, Wheel, and Sage Bionetworks.

This edition of Healthcare Hires of Note is presented by SnapNurse
SnapNurse, which matches quality nurses and medical professionals with employment opportunities nationwide, has named Jeff Grant as its new CEO. Grant will focus on catalyzing growth of SnapNurse’s tech platform, which makes it easy to place and onboard qualified healthcare clinicians. The platform powers scale and quality for both facilities and medical professionals.

Jeff Grant

Grant is a technology executive with an extraordinary track record of success in catalyzing growth of tech-enabled marketplaces. He previously served as COO at Thumbtack, CEO of DriversEd and CEO of insuranceQuotes, digital solutions providers that all experienced substantial growth under Grant’s leadership. Grant also held key leadership roles at LeapFrog and Orbitz.

He received his MBA from the Kellogg School of Management at Northwestern University and his undergraduate degree in Business Administration from the University of Michigan.
He succeeds Jeff Richards, who will continue with the company as Chief Operating Officer and a member of the Board of Directors.
To read more, click here.

Almaden Genomics has named David Gascoigne as CEO. A life sciences industry veteran with three decades of leadership experience scaling businesses from early stage to prominent market position, Gascoigne will leverage his background in integrative healthcare data analytics to drive Almaden as it accelerates genomic research and discovery through streamlined bioinformatics.

Gascoigne joins Almaden from Sutherland Global Services where he
served as head of healthcare analytics.

“David is a significant addition to the original Almaden team of bioinformaticians,
engineers, and industry professionals that developed g.nome, our cloud-native platform designed to streamline genomic workflows,” said Tricia D’Cruz, executive chairperson of Almaden Genomics. “After spinning out Almaden as a standalone company late last year, we found an executive that possesses a deep understanding of health sciences, integrated data sets, and machine learning who also has a proven record of successfully building and scaling businesses. We couldn’t be more thrilled to welcome David to this role.”

Almaden’s g.nome dramatically accelerates bioinformatic pipeline building from what previously has taken months to mere hours, according to a press release.

To read more, click here., the global leader in transforming the smartphone camera into a medical device, today announced the hiring of Justin Garrett as its Vice President of US Payer Sales. Justin previously served as Vice President of Commercial Markets at PillPack, which was acquired by Amazon in 2018. Post acquisition, he led Amazon Pharmacy’s Payer Mail-Order service offering and brings with him a deep understanding of the payer market with a particular focus on simplifying the member experience and improving member outcomes.

In addition, the company has hired Scott Gagnon to be its vice president of U.S. Operations. Before joining, Gagnon served as Vice President of Program Operations at Adheris Health and was a member of their executive leadership team. His areas of expertise are in large scale program operations and business operations in the pharmacy space.

“As we enter 2023, we are seeing strong tailwinds from our 2022 FDA approval and the recently proposed inclusion of KED as a STAR measure,” Founder and CEO Yonatan Adiri said. “We are confident that both Justin and Scott will be valuable additions to our executive team and will help build on the momentum behind our company and the growth of at-home testing across the nation.”

The board of directors for Dr. Evidence, a platform for life sciences companies , has appointed Rose Higgins as CEO. She will take over from co-founder and CEO, Bob Battista, who has been CEO since the company’s founding in 2004 and will continue to serve on the board of directors.

Higgins was most recently CEO of HealthMyne, a pioneering radiomics company whose IP and technology assets were acquired by Genentech (a Roche company) in 2022. She began her career in nursing at the University of Pittsburgh Medical Center, followed by advancing roles in clinical and care management.

To read more, click here.

Luca Foschini has joined Sage Bionetworks as CEO and President.

He previously worked at Evidation Health for 10 years. In a LinkedIn post announcing his move, Foschini wrote:

“Building out the health #datascience organization at Evidation, it has been incredibly rewarding to turn Person-Generated Health Data (#PGHD) into evidence for pharma and biotech, evidence that has meaningfully helped patients.

“That journey has also made me realize the great opportunity we collectively have as a society to more effectively utilize the data companies and research participants are spending so much resources to create. ”

To learn more, click here.

Wheel, a health tech company, has added Vincent Balsamo as Chief Revenue Officer. Balsamo joins Wheel following its acquisition of GoodRx Care’s backend virtual care technology and as the company continues its expansion into new markets, including retailers and urgent care centers. He will be a key leader in driving Wheel’s go-to-market strategy across the company’s current and future markets and be responsible for revenue performance.

“Vince is a mission-driven leader with a passion for reimagining care delivery and a strong track record of helping companies scale and deliver measurable outcomes,“ said Michelle Davey, CEO and co-founder of Wheel. “Vince’s expertise will be critical as we continue to expand into new markets and power high quality virtual-first care on behalf of even more enterprises.”

To learn more, click here.

Photo: siraanamwong, Getty Images